Wednesday, Jun 25, 2025 · SEC filings
What the smart money revealed on Jun 25
287 insider filings came in. We hid 48 planned (10b5-1) sellers and 175 people whose filings were routine, like grants and tax withholding.
Vera Therapeutics (VERA) Director Patrick Enright bought $5.28M
250,000 shares on the open market. Not a grant or an option exercise. Their past buys: 2 of 5 checked quarters beat the typical stock 6 months later.
Global Medical REIT (GMRE) CEO and President Mark Decker Jr. bought $1.04M
160,000 shares on the open market. Not a grant or an option exercise.
Prospect Capital (PSEC) CEO John Barry bought $1.01M
319,000 shares on the open market. Not a grant or an option exercise. Their past buys: 0 of 6 checked quarters beat the typical stock 6 months later.
SafeSpace Global (SSGC) Pres and Chief Strat Officer Dustin Hillis bought $636K
Open-market buys of more than one share class. Not a grant or an option exercise.
Broadcom (AVGO) Chief Legal and Corp Affairs Ofc Mark Brazeal sold $12.7M
Not marked as a planned 10b5-1 sale. Sold 11% of the shares they held directly. Still holds 415,956 shares.
Broadcom (AVGO) President and CEO Hock Tan sold $10.5M
Not marked as a planned 10b5-1 sale. Sold 4% of the shares they held directly. Still holds 974,152 shares.
BeOne Medicines (ONC) CEO John Oyler sold $830K
Not marked as a planned 10b5-1 sale. Sold every share held directly.
Show 14 more real buys
Show 29 more real sales
13F season
Holdings as of Mar 31, 2025 were due May 15
92 funds have filed. 80 filed for the quarter before.
Biggest real insider buys, Jun 19–25
Open-market buys by officers and directors, filed in the 7 days up to Jun 25.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.